Finland· FI-REL-REL57698
RenuTend
A hevosen kantasolut product containing tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells, registered in Finland by Boehringer Ingelheim Vetmedica GmbH. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells is registered in 2 of 19 countries.
Countries holding a registration under ATC QM09AX90 (hevosen kantasolut), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells · ATC QM09AX90
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells
- Manufacturer
- Boehringer Ingelheim Vetmedica GmbH
- Country
- Finland (FI)
- ATC code
- QM09AX90
- ATC class
- hevosen kantasolut
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QM09AX90
Hevosen kantasolut, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdcf95ab-95c1-473a-8536-c2446dd45135 GET /v1/drugs/cdcf95ab-95c1-473a-8536-c2446dd45135?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, suspensio",
"route": "Kudosvaurioon, leesioon",
"ddd_unit": null,
"strength": null,
"atc_label": "hevosen kantasolut",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/2/22/282/001",
"fimea_rel_id": "REL57698",
"authorised_at": "2022-04-19"
}See everything about tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.